Marco A Pierotti Selected Research

Marco A Pierotti Research Topics

Disease

64	Neoplasms (Cancer) 01/2023 - 11/2002
17	Breast Neoplasms (Breast Cancer) 04/2016 - 09/2002
10	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 12/2005
7	Papillary Thyroid Cancer 02/2013 - 08/2002
6	Carcinoma (Carcinomatosis) 01/2017 - 08/2005
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2012 - 07/2004
5	Carcinogenesis 05/2015 - 09/2003
5	Melanoma (Melanoma, Malignant) 10/2014 - 06/2005
4	Adenocarcinoma 03/2014 - 06/2003
4	Chordoma 01/2014 - 11/2004
4	Lung Neoplasms (Lung Cancer) 03/2010 - 11/2003
4	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2006 - 02/2002
3	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2005
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 02/2002
3	Squamous Cell Carcinoma of Head and Neck 10/2015 - 11/2006
3	Thyroid Neoplasms (Thyroid Cancer) 02/2013 - 09/2010
3	Follicular Adenocarcinoma 02/2013 - 10/2005
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2010 - 07/2004
3	Multiple Endocrine Neoplasia Type 2b (MEN 3) 10/2006 - 11/2002
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 10/2006 - 04/2004
2	Familial Breast Cancer 09/2015 - 10/2008
2	Genomic Instability 08/2015 - 10/2010
2	Solitary Fibrous Tumors 08/2015 - 05/2010
2	Disease Progression 01/2014 - 01/2014
2	Inflammation (Inflammations) 09/2011 - 10/2005
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2007 - 10/2006
2	Ewing Sarcoma (Sarcoma, Ewing) 04/2007 - 07/2003
2	Familial medullary thyroid carcinoma 04/2006 - 04/2004
2	Hirschsprung Disease (Hirschsprung's Disease) 04/2006 - 05/2003
2	Ovarian Neoplasms (Ovarian Cancer) 10/2004 - 12/2002
1	Chronic Disease (Chronic Diseases) 01/2017
1	Circulating Neoplastic Cells 01/2015
1	Genetic Translocation (Chromosomal Translocation) 12/2014
1	Neoplastic Processes 05/2014
1	Liposarcoma 11/2013
1	Anaplastic Thyroid Carcinoma 02/2013
1	Clear Cell Sarcoma 02/2012
1	Fibrosis (Cirrhosis) 09/2011
1	Oncogene Addiction 07/2011
1	medullary Thyroid cancer 02/2011

Drug/Important Bio-Agent (IBA)

11	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2015 - 11/2002
11	Phosphotransferases (Kinase)IBA 12/2014 - 02/2002
11	Imatinib Mesylate (Gleevec)FDA Link 08/2013 - 07/2003
10	Proteins (Proteins, Gene)FDA Link 08/2015 - 08/2002
9	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 11/2003
7	Estrogen ReceptorsIBA 04/2016 - 06/2005
5	LigandsIBA 09/2010 - 02/2004
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2010 - 02/2004
4	MicroRNAs (MicroRNA)IBA 06/2015 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 01/2015 - 06/2004
4	Cell-Free Nucleic AcidsIBA 03/2014 - 11/2003
4	Protein Isoforms (Isoforms)IBA 11/2013 - 08/2002
4	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2010 - 11/2004
4	Complementary DNA (cDNA)IBA 06/2008 - 09/2004
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006 - 11/2002
3	Oncogene Proteins (Oncogene Protein)IBA 08/2015 - 08/2002
3	Cyclin D1IBA 01/2014 - 11/2006
3	RNA (Ribonucleic Acid)IBA 04/2012 - 09/2003
3	Messenger RNA (mRNA)IBA 04/2012 - 02/2004
3	tyrosine receptor (receptor, tyrosine)IBA 08/2010 - 02/2002
3	EnzymesIBA 05/2009 - 09/2004
3	Tyrosine Kinase InhibitorsIBA 02/2009 - 07/2004
3	Tamoxifen FDA LinkGeneric 09/2008 - 06/2005
3	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2006 - 06/2003
3	3-(2-carboxyindol-3-yl)propionic acidIBA 01/2006 - 02/2002
3	Protein Kinases (Protein Kinase)IBA 09/2005 - 09/2004
2	CytokinesIBA 12/2015 - 10/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015 - 12/2014
2	Tumor Biomarkers (Tumor Markers)IBA 04/2012 - 10/2008
2	AntigensIBA 07/2011 - 07/2006
2	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 02/2011 - 03/2008
2	Beclin-1IBA 10/2010 - 12/2008
2	Sunitinib (Sutent)FDA Link 05/2010 - 02/2009
2	Estrogen Receptor alphaIBA 06/2008 - 05/2008
2	beta CateninIBA 09/2007 - 10/2006
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 09/2003 - 06/2003
2	trkA ReceptorIBA 02/2003 - 10/2002
1	Decellularized Extracellular MatrixIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 11/2017
1	pazopanib FDA Link 02/2016
1	Nonsense Codon (Nonsense Mutation)IBA 09/2015
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2015
1	Epithelial Cell Adhesion MoleculeIBA 01/2015
1	AntibodiesIBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 10/2014
1	human ERBB2 proteinIBA 03/2014
1	Biological FactorsIBA 03/2014
1	Laminin ReceptorsIBA 03/2014
1	CateninsIBA 01/2014
1	nutlin 3IBA 11/2013
1	prolinedithiocarbamate (PDTC)IBA 02/2013
1	Complement System Proteins (Complement)IBA 04/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011
1	Conditioned Culture MediaIBA 02/2011
1	Trastuzumab (Herceptin)FDA Link 10/2010

Therapy/Procedure

14	Therapeutics 01/2017 - 09/2004
7	Drug Therapy (Chemotherapy) 03/2014 - 12/2002
1	Precision Medicine 01/2017
1	Salvage Therapy 02/2016
1	Lymph Node Excision (Lymph Node Dissection) 03/2014